Why does null hypothesis testing matter for HCV replication detection?

Null hypothesis testing ensures that observed colocalization of HCV protein and dsRNA is statistically significant, reducing false positives in target validation. This strengthens confidence in distinguishing true replication events from background signal. Reliable statistical analysis underpins robust antiviral discovery decisions.

How does independent variable isolation fit the immunofluorescence workflow?

Isolating variables such as antibody specificity and incubation conditions allows teams to attribute observed signals directly to HCV replication. This isolation is critical for mechanistic de-risking and for validating assay outputs in early discovery. Controlled conditions support reproducible and interpretable results.

What do quantitative dual-marker measurements enable in HCV assays?

Quantitative measurement of both HCV protein and dsRNA enables precise assessment of replication status and compound efficacy. These outputs facilitate direct comparison across experimental arms and inform data-driven advancement decisions. Quantitative readouts are essential for screening and portfolio triage.

Why are replication requirements important for cross-functional collaboration?

Replication requirements ensure that assay results are reproducible across teams and sites, supporting cross-functional data integration. Consistent replication builds trust in assay outputs for downstream screening and translational research. Standardized protocols enable seamless collaboration in enterprise R&D environments.

What statistical analysis capabilities are required before assay implementation?

Robust statistical analysis is needed to validate signal specificity, quantify colocalization, and assess assay sensitivity. These capabilities ensure that only statistically significant findings inform target validation and compound progression. Pre-implementation analytics reduce risk of false discovery in antiviral pipelines.

Immunofluorescence Assay to Detect Hepatitis C Virus Replication Complexes in Infected Cells

JoVE Encyclopedia of Experiments

Microbiology

0 views • 2:53 min • July 31st, 2026

$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Take Hepatitis C virus RNA or HCV RNA-transfected hepatoma cells. The RNA encodes an HCV protein that helps replicate viral single-stranded RNA into double-stranded RNA or dsRNA.
Add a fixative to permeabilize the cellular membranes and preserve cellular integrity.
Remove the fixative and wash with a buffer to ensure complete fixative removal.
Add a blocking solution to prevent non-specific antibody binding.
Add two primary antibodies, one specific to the HCV protein, and the other targeting viral dsRNA.
Incubate to facilitate the binding of the primary antibodies to the HCV protein and dsRNA.
Wash to remove unbound antibodies.
Introduce fluorophore-conjugated secondary antibodies and incubate with agitation.
The secondary antibodies bind to their specific primary antibodies.
Wash to remove unbound secondary antibodies.
Add a nuclear dye to stain the cell nuclei.
Observe under a fluorescence microscope.
Colocalization of dual signals confirms replication of HCV within the host cell.
Fix the HCV RNA-transfected cells using methanol for 30 minutes at negative 20 degrees Celsius for the immunofluorescence assay.
When finished, wash the cells with PBS 3 times. After blocking with immunofluorescence assay blocking buffer, use rabbit polyclonal anti-NS5A primary antibody and mouse monoclonal anti-dsRNA antibody J2 at a dilution of 1 to 200, and incubate for five hours to overnight in a four degrees Celsius cold room.
Following incubation, wash the cells with PBS 3 times after the primary antibody. Then, add goat anti-rabbit IgG-488 polyclonal secondary antibody and goat anti-mouse IgG-594 polyclonal secondary antibody at a one-in-1000 dilution and incubate for one hour at room temperature on a tabletop rocker.
After washing the cells with PBS 3 times, stain the nuclei using Hoechst dye and view using a fluorescent microscope.